Figure 8 HRQOL in individuals with RA

Slides:

Advertisements

Similar presentations

Figure 1 Venomous snakes

Advertisements

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Incidence and mortality of cutaneous melanoma

Figure 2 Electromechanical properties of OIHPs

Figure 6 Selected examples of TERS applications in material systems

Figure 1 Anatomy of the spinal column

Vibeke Strand, MD, MACR, Jasvinder A. Singh, MD, MPH

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Proportion of patients reporting scores ≥age-matched and gender-matched normative PRO values at baseline and 24 weeks in the (A) AMBITION and (B) ADACTA.

Nat. Rev. Rheumatol. doi: /nrrheum

Reproduced with permission from Yancy, C. W. et al. 2017

Figure 8 Implanted devices for the management of heart failure

Nat. Rev. Nephrol. doi: /nrneph

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.

Figure 7 European Society of Cardiology 2016

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 The network of chronic diseases and their mutual influences

Figure 2 Shared genetic loci in systemic autoimmune diseases

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Figure 6 Imaging methods used to study Parkinson disease

Figure 3 Possible modalities for reconciliation of patient's and physician's report of symptomatic treatment-associated toxicities Figure 3 | Possible.

Nat. Rev. Rheumatol. doi: /nrrheum

Work arrangements, productivity, and self-confidence at work as affected by RA. a For example: Stopped working altogether, moved from full-time to part-time.

Figure 1 Cardiovascular risk and disease across the life-course

Figure 2 Incidence of multiple myeloma in 2012

Figure 2 Global cost of HF per capita in 2012

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Template for standard pelvic lymphadenectomy

Conversion to ACPA and RF seronegative status in patients with early RA treated with abatacept+MTX compared with MTX alone. Conversion to ACPA and RF seronegative.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Bioresorbable vascular scaffold apposition and strut coverage

Mean DAS (A), HAQ (B) and percentages in low disease activity, DAS remission and drug-free DAS remission (C) during 5 years in the DAS ≤2.4 steered (BeSt)

Figure 4 Diagnosing neuropathic pain

Figure 1 Structure of ADAMTS13

Adapted with permission from Tesfaye, S. , Boulton, A. J

Figure 9 Management of atrial fibrillation

Figure 2 Global mortality and incidence rates of pancreatic cancer

Nat. Rev. Cardiol. doi: /nrcardio

Figure 7 Prototypes of topological mechanical metamaterials

The severity of fatigue over 8 years of disease in early rheumatoid arthritis patients. The severity of fatigue over 8 years of disease in early rheumatoid.

Figure 2 Global kidney cancer incidence

Figure 4 4D printing schemes and time-evolving structure geometries

Figure 1 Worldwide prevalence of MRSA

Percentage of patients reporting improvements ≥MCID and NNTs to achieve an MCID in (A) PtGA, (B) pain, (C) HAQ-DI, (D) FACIT-F and (E) SF-36 domains and.

Nat. Rev. Cardiol. doi: /nrcardio

SF-36 domain scores at baseline and 24 weeks compared with age-matched and gender-matched normative values in the (A) AMBITION and (B) ADACTA trial populations.

The association between alcohol consumption and the severity of MRI-detected inflammation in hand and foot joints of (A) patients with RA and (B) asymptomatic.

Clinical response in patients with early and established RA at month 24. *p

Figure 4 Treponema pallidum invasion

Figure 5 Algorithm for the management of hypertension

Figure 1 Treponema pallidum

Mean Short-Form 36 (SF-36) domain scores at baseline and 6 months in patients receiving active or placebo corticosteroids, cDMARDs or TNFis. Mean Short-Form.

Percentage of patients achieving 20% improvement in the American College of Rheumatology criteria at week 12 by patient demographic and disease characteristics.

Malignancy-related events over time for all-bari-RA analysis set (IR).

Ultrasonographic characteristics and synovitis pattern of patients with inflammatory bowel disease (IBD) with onset of peripheral arthritis under tumour.

Study design. *Randomisation stratified by corticosteroid use at baseline. Study design. *Randomisation stratified by corticosteroid use at baseline. DAS28-CRP,

Preferred Reporting Items for Systematic Review and Meta-Analysis diagram of studies evaluating patients with SAP and with AP before reclassification.

Satisfaction with control of RA

Figure 4 Clinical manifestations of alopecia areata

Part b is reproduced with permission from Messenger, A. G

(A) Mean NMR spectra of patient sera show differences in metabolite intensities between responders and non-responders before (a) and 6 months after (b)

Nat. Rev. Mater. doi: /natrevmats

Forest plot showing the results of the meta-analysis on the effect of strength exercise on M.quadriceps femoris in people with rheumatoid arthritis and.

Forest plot showing the results of the meta-analysis on the effect of aerobic exercise on measured on VO2max in people with rheumatoid arthritis, spondyloarthritis.

ACPA and RF titres in patients with early RA treated with abatacept+MTX compared with MTX alone. ACPA and RF titres in patients with early RA treated with.

Post hoc analysis of differences from placebo in the percentage of patients reporting improvements ≥MCID at week 24. Post hoc analysis of differences from.

Changes in non-classical (CD11b+CD14+CD163−CD16+) and classical (CD11b+CD14+CD163+CD16−) monocytes over time in patients with rheumatoid arthritis (RA)

Presentation transcript:

Figure 8 HRQOL in individuals with RA Part a is adapted with permission from Matcham, F. et al. The impact of rheumatoid arthritis on quality-of‑life assessed using the SF‑36: a systematic review and meta-analysis. Semin. Arthritis Rheum. 44, 123–130 (2014), Elsevier. Parts b and c adapted from Scott, I. C., Ibrahim, F., Lewis, C. M., Scott, D. L. & Strand, V. Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis. RMD Open 2, e000270 (2016), CC BY 4.0 Smolen, J. S. et al. (2018) Rheumatoid arthritis Nat. Rev. Dis. Primers doi:10.1038/nrdp.2018.1